KINEVAC Drug Patent Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
When do Kinevac patents expire, and when can generic versions of Kinevac launch?
Kinevac is a drug marketed by Bracco and is included in one NDA. There is one patent protecting this drug.
This drug has ten patent family members in eight countries.
The generic ingredient in KINEVAC is sincalide. There are three drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the sincalide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Kinevac
A generic version of KINEVAC was approved as sincalide by MAIA PHARMS INC on November 22nd, 2022.
Summary for KINEVAC
| International Patents: | 10 |
| US Patents: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 45 |
| Clinical Trials: | 1 |
| Patent Applications: | 2,084 |
| Drug Prices: | Drug price information for KINEVAC |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for KINEVAC |
| What excipients (inactive ingredients) are in KINEVAC? | KINEVAC excipients list |
| DailyMed Link: | KINEVAC at DailyMed |
Recent Clinical Trials for KINEVAC
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Penn State University | N/A |
| Memorial Health University Medical Center | N/A |
| Temple University | N/A |
Pharmacology for KINEVAC
| Drug Class | Cholecystokinin Analog |
Anatomical Therapeutic Chemical (ATC) Classes for KINEVAC
US Patents and Regulatory Information for KINEVAC
KINEVAC is protected by one US patents.
Patents protecting KINEVAC
Sincalide formulations
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bracco | KINEVAC | sincalide | INJECTABLE;INJECTION | 017697-001 | Approved Prior to Jan 1, 1982 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for KINEVAC
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Bracco | KINEVAC | sincalide | INJECTABLE;INJECTION | 017697-001 | Approved Prior to Jan 1, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
| Bracco | KINEVAC | sincalide | INJECTABLE;INJECTION | 017697-001 | Approved Prior to Jan 1, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for KINEVAC
See the table below for patents covering KINEVAC around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Japan | S4813114 | ⤷ Try a Trial | |
| Denmark | 132074 | ⤷ Try a Trial | |
| European Patent Office | 1631305 | FORMULATIONS A BASE DE SINCALIDE (SINCALIDE FORMULATIONS) | ⤷ Try a Trial |
| Australia | 2003304382 | Sincalide formulations | ⤷ Try a Trial |
| Canada | 2503982 | FORMULATIONS A BASE DE SINCALIDE (SINCALIDE FORMULATIONS) | ⤷ Try a Trial |
| France | 2007810 | ⤷ Try a Trial | |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2023 - 2024
NCE-1 Patent Challenge Dates 2023 - 2024
DrugChatter - AI-based answers to questions about drugs
RxJam - Trigger-based marketing for life sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2023, www.DrugPatentWatch.com.
Follow DrugPatentWatch:
